"USE OF DIPYRIDAMOLE OR MOPIDAMOLE FOR TREATMENT AND PREVENTION OF THROMBO-EMBOLIC DISEASES AND DISORDERS CAUSED BY EXCESSIVE FORMATION OF THROMBIN AND/OR BY ELEVATED EXPRESSION OF THROMBIN RECEPTORS"
Application 4622/DELNP/2005 published 2007-09-28, filed 2005-10-13
A method of treatment of the human or non-human animal body for treating or preventing disorders caused by elevated thrombin or elevated thrombin receptor expression is disclosed, for example thromboembolic disease vascular syndromes, or proliferative diseases, which method comprises administering to a human or non-human animal body in need of such treatment an effective amount of a pharmaceutical composition containing dipyridamole, mopidamole or a pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions as well as the use of dipyridamole or mopidamole for the manufacture of these pharmaceutical compositions.
Applicant
1)BOEHRINGER INGELHEIM INTERNATIONAL GMBH
:BINGER STRASSE 173, 55216 INGELHEIM, GERMANY Germany
Inventor
1)WOLFGANG EISERT. 2)VICTOR L. SEREBRUANY
International Info
Classification: A61K 31/519
Publication Number: WO 2004/093881
Application Date: 2004-04-17
Priority Information
60/465,168 U.S.A. 2003-04-24